Orion Corporation withdraws its application for an extension of indication for Stalevo (levodopa/carbidopa/entacapone)

View source ↗

Summary

Orion Corporation has withdrawn its application to extend the indication for Stalevo (levodopa/carbidopa/entacapone).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease with Fluctuations

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)